AHA ACLS is a specialized medical utility designed to assist clinicians in managing cardiac arrest and post-cardiac arrest care. Developed by Massachusetts General Hospital and endorsed by the AHA, it provides high-fidelity, evidence-based algorithms and real-time logging tools. It is highly regarded for its clinical authority and intuitive design, but faces significant backlash due to its subscription-based monetization model. The app's primary differentiator is its official endorsement and vetting by the AHA and Harvard-affiliated physicians. While it provides essential point-of-care support, the recent shift to a subscription model has created a critical friction point, with users expressing concerns over the ethics of paywalling life-saving software during active patient care.